AR016350A1 - Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos - Google Patents
Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentosInfo
- Publication number
- AR016350A1 AR016350A1 ARP980103482A ARP980103482A AR016350A1 AR 016350 A1 AR016350 A1 AR 016350A1 AR P980103482 A ARP980103482 A AR P980103482A AR P980103482 A ARP980103482 A AR P980103482A AR 016350 A1 AR016350 A1 AR 016350A1
- Authority
- AR
- Argentina
- Prior art keywords
- insulin
- agent
- heritage
- alfa
- secretagog
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/702—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
Abstract
Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucémico inhibidor de alfa-glucosidasa, para preparar un medicamentoutil para el tratamiento de la diabetes mellitus y las condiciones asociadas con la diabetes mellitus que comprende una cantidad eficaz no toxica yfarmacéuticamente aceptable de dichos compuestos y al menos un vehículo farmacéuticamente aceptable.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9715298A GB9715298D0 (en) | 1997-07-18 | 1997-07-18 | Novel method of treatment |
Publications (1)
Publication Number | Publication Date |
---|---|
AR016350A1 true AR016350A1 (es) | 2001-07-04 |
Family
ID=10816170
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP980103482A AR016350A1 (es) | 1997-07-18 | 1998-07-16 | Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos |
ARP990103110A AR019724A2 (es) | 1997-07-18 | 1999-06-28 | Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP990103110A AR019724A2 (es) | 1997-07-18 | 1999-06-28 | Composicion farmaceutica util para el tratamiento de diabetes mellitus y condiciones asociadas |
Country Status (27)
Country | Link |
---|---|
EP (1) | EP1001784A1 (es) |
JP (1) | JP2001510160A (es) |
KR (1) | KR20010021952A (es) |
CN (1) | CN1263467A (es) |
AP (1) | AP2000001735A0 (es) |
AR (2) | AR016350A1 (es) |
AU (1) | AU8449098A (es) |
BG (1) | BG104062A (es) |
BR (1) | BR9810292A (es) |
CA (1) | CA2297133A1 (es) |
CO (1) | CO4940489A1 (es) |
DZ (1) | DZ2563A1 (es) |
EA (1) | EA200000140A1 (es) |
GB (1) | GB9715298D0 (es) |
HU (1) | HUP0003626A3 (es) |
ID (1) | ID23804A (es) |
IL (1) | IL133907A0 (es) |
MA (1) | MA24608A1 (es) |
NO (1) | NO20000230D0 (es) |
OA (1) | OA11312A (es) |
PE (1) | PE99499A1 (es) |
PL (1) | PL338140A1 (es) |
SK (1) | SK612000A3 (es) |
TR (1) | TR200000133T2 (es) |
UY (1) | UY25101A1 (es) |
WO (1) | WO1999003478A1 (es) |
ZA (1) | ZA986364B (es) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
ES2291210T3 (es) * | 1999-06-21 | 2008-03-01 | Eli Lilly And Company | Uso sinergistico de tiazolidindionas con peptido-1 tipo glucagona y sus agonistas para tratar la diabetes no insulina-dependiente. |
BRPI0107715B8 (pt) * | 2000-01-21 | 2021-05-25 | Novartis Ag | produto farmacêutico compreendendo um inibidor de dipeptidilpeptidase-iv e metformina, bem como usos do dito produto farmacêutico e do inibidor de dipeptidilpeptidase-iv |
EP1295609A4 (en) * | 2000-02-24 | 2004-11-03 | Takeda Chemical Industries Ltd | DRUGS CONTAINING COMBINED ACTIVE INGREDIENTS |
JP4917712B2 (ja) * | 2000-02-24 | 2012-04-18 | 武田薬品工業株式会社 | 併用医薬 |
JP4633329B2 (ja) | 2001-01-12 | 2011-02-16 | サン・ファーマ・アドバンスド・リサーチ・カンパニー・リミテッド | スペーストドラッグデリバリーシステム |
FR2832930A1 (fr) * | 2001-12-03 | 2003-06-06 | Lipha | Composition pharmaceutique comprenant un inhibiteur d'alpha-glucosidase et un derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
NZ546337A (en) | 2003-10-31 | 2009-03-31 | Takeda Pharmaceutical | Solid preparation comprising an insulin sensitizer such as pioglitazone hydrochloride, an insulin secretagogue such as glimepiride and a polyoxyethylene sorbitan fatty acid ester such as Polysorbate 80 |
CN101103993B (zh) * | 2006-07-14 | 2011-03-30 | 北京华安佛医药研究中心有限公司 | 降糖药物组合物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2101866T3 (es) * | 1991-08-26 | 1997-07-16 | Upjohn Co | Producto alimentario liquido que contiene acido 3-guanidinopropionico. |
US5917052A (en) * | 1994-09-28 | 1999-06-29 | Shaman Pharmaceuticals, Inc. | Hypoglycemic agent from cryptolepis |
TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
-
1997
- 1997-07-18 GB GB9715298A patent/GB9715298D0/en active Pending
-
1998
- 1998-07-15 DZ DZ980173A patent/DZ2563A1/xx active
- 1998-07-16 AU AU84490/98A patent/AU8449098A/en not_active Abandoned
- 1998-07-16 MA MA25172A patent/MA24608A1/fr unknown
- 1998-07-16 CA CA002297133A patent/CA2297133A1/en not_active Abandoned
- 1998-07-16 BR BR9810292-3A patent/BR9810292A/pt not_active IP Right Cessation
- 1998-07-16 IL IL13390798A patent/IL133907A0/xx unknown
- 1998-07-16 EP EP98935129A patent/EP1001784A1/en not_active Withdrawn
- 1998-07-16 AR ARP980103482A patent/AR016350A1/es unknown
- 1998-07-16 EA EA200000140A patent/EA200000140A1/ru unknown
- 1998-07-16 TR TR2000/00133T patent/TR200000133T2/xx unknown
- 1998-07-16 KR KR1020007000517A patent/KR20010021952A/ko not_active Application Discontinuation
- 1998-07-16 HU HU0003626A patent/HUP0003626A3/hu unknown
- 1998-07-16 SK SK61-2000A patent/SK612000A3/sk unknown
- 1998-07-16 JP JP2000502777A patent/JP2001510160A/ja active Pending
- 1998-07-16 CN CN98807147A patent/CN1263467A/zh active Pending
- 1998-07-16 PL PL98338140A patent/PL338140A1/xx unknown
- 1998-07-16 PE PE1998000630A patent/PE99499A1/es not_active Application Discontinuation
- 1998-07-16 WO PCT/GB1998/002112 patent/WO1999003478A1/en not_active Application Discontinuation
- 1998-07-16 ID IDW20000077A patent/ID23804A/id unknown
- 1998-07-17 CO CO98040749A patent/CO4940489A1/es unknown
- 1998-07-17 UY UY25101A patent/UY25101A1/es not_active Application Discontinuation
- 1998-07-17 ZA ZA9806364A patent/ZA986364B/xx unknown
-
1999
- 1999-06-28 AR ARP990103110A patent/AR019724A2/es unknown
-
2000
- 2000-01-06 BG BG104062A patent/BG104062A/xx unknown
- 2000-01-14 AP APAP/P/2000/001735A patent/AP2000001735A0/en unknown
- 2000-01-17 NO NO20000230A patent/NO20000230D0/no not_active Application Discontinuation
- 2000-01-18 OA OA1200000013A patent/OA11312A/en unknown
Also Published As
Publication number | Publication date |
---|---|
PL338140A1 (en) | 2000-09-25 |
SK612000A3 (en) | 2000-07-11 |
ZA986364B (en) | 2000-01-17 |
CN1263467A (zh) | 2000-08-16 |
NO20000230L (no) | 2000-01-17 |
GB9715298D0 (en) | 1997-09-24 |
WO1999003478A1 (en) | 1999-01-28 |
UY25101A1 (es) | 2000-12-29 |
AR019724A2 (es) | 2002-03-13 |
HUP0003626A3 (en) | 2001-12-28 |
BG104062A (en) | 2000-11-30 |
DZ2563A1 (fr) | 2003-02-15 |
TR200000133T2 (tr) | 2000-09-21 |
CO4940489A1 (es) | 2000-07-24 |
ID23804A (id) | 2000-05-11 |
EP1001784A1 (en) | 2000-05-24 |
AU8449098A (en) | 1999-02-10 |
MA24608A1 (fr) | 1999-04-01 |
NO20000230D0 (no) | 2000-01-17 |
IL133907A0 (en) | 2001-04-30 |
PE99499A1 (es) | 1999-12-18 |
KR20010021952A (ko) | 2001-03-15 |
BR9810292A (pt) | 2000-09-19 |
CA2297133A1 (en) | 1999-01-28 |
OA11312A (en) | 2003-10-24 |
JP2001510160A (ja) | 2001-07-31 |
HUP0003626A2 (hu) | 2001-05-28 |
AP2000001735A0 (en) | 2000-01-16 |
EA200000140A1 (ru) | 2000-06-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20090846L (no) | Kombinasjon og farmasoytisk blanding for behandling av diabetes samt anvendelse derav | |
UY25799A1 (es) | Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina y otro agente antidiabético. | |
MX9202407A (es) | Composicion farmaceutica que contiene un compuesto de alilamina como el agente activo y proceso para su preparacion. | |
AR013742A1 (es) | Metodo para el tratamiento de la hipercolesterolemia con polidialilamina no substituida | |
AR016350A1 (es) | Uso de un sensibilizador a insulina, un secretagogo de insulina y un agente antihiperglucemico inhibidor de alfa-glucosidasa para prepararmedicamentos | |
BR9810445A (pt) | Tratamento de diabete com tiazolidinadiona, secretagogo de insulina e diguanida | |
UY25798A1 (es) | Composición farmacéutica de liberación modificada que comprende un sensibilizador de insulina tiazolidinadiónico. | |
ES2131122T3 (es) | Uso de il-10 para prevenir la diabetes mellitus dependiente de insulina. | |
CO4940454A1 (es) | Nuevo metodo de tratamiento | |
UY25103A1 (es) | Composición para el tratamiento de diabetes mellitus | |
AR013352A1 (es) | Uso de un sensibilizador a insulina y un agente antihiperglucemico para la preparacion de un medicamento para el tratamiento de la diabetes mellitus ycondiciones asociadas a la misma y una composicion farmaceutica. | |
AR008025A1 (es) | Combinación farmacéutica de una tiazolidindiona y un secretagogo de insulina | |
HUP0104388A2 (hu) | Béta-agonistákból és további antidiabetikus szerekből álló kombinációk | |
ECSP982541A (es) | Nuevo metodo de tratamiento ii | |
UY25801A1 (es) | Procedimiento para preparar composiciones para el tratamiento de diabetes. | |
ECSP982593A (es) | Nuevo metodo de tratamiento vi | |
ECSP982592A (es) | Nuevo metodo de tratamiento v | |
ECSP982591A (es) | Nuevo metodo de tratamiento iv | |
ECSP982535A (es) | Nuevo metodo de tratamiento (i) | |
ECSP982542A (es) | Nuevo metodo de tratamiento iii | |
ECSP993215A (es) | Nueva composicion y uso | |
AP1692A (en) | Pharmaceutical composition for modified release of an insulin sensitiser and another antidiabetic agent. | |
BR9815220A (pt) | Uso de tiazolidinedionas para o tratamento da hiperglicemia | |
BR9815219A (pt) | Uso de tiazolidinedionas para o tratamento da hiperglicemia |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |